Surfacide Testimonial - APIC 2022 скачать в хорошем качестве

Surfacide Testimonial - APIC 2022

At APIC 2022 in Indianapolis, Indiana, Surfacide founder and CEO Gunner Lyslo shares how his company pioneered the Helios triple-emitter system, which today is installed in more than 500 hospitals in the US alone. Lyslo explains that UVC Dosimeters are critical tools to show healthcare facilities the unique advantage of Surfacide's three-tower system by providing visible proof that invisible energy is being delivered. When it comes to transparency in how UV-C devices perform, Surfacide is taking the lead and encourages anyone who uses or is considering implementing UV-C devices, to use UVC Dosimeters by Intellego. "It will prove to you whether or not that modality is delivering the energy that they say it's delivering, " explains Lyslo. To learn more about Surfacide and the Helios triple-emitter system, visit: https://www.surfacide.com/ For more information on Intellego Technologies and UVC Dosimeters, visit: https://intellego-technologies.com/ https://uvcdosimeters.com/